Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus

BMC Endocrine Disorders

Table 4 Log-rank test and Cox regression model of sex, age, FLD and other metabolic disorders for T2DM

	χ² value^a	P value^b	HR^c	P value^d	HR^e	P value^f
FLD	554.96	< 0.01	1.98(1.76,2.23)	< 0.01	NA	NA
male sex	187.81	< 0.01	1.52(1.35,1.71)	< 0.01	1.55(1.37,1.75)	< 0.01
middle-aged and elderly	420.28	< 0.01	2.36(2.11,2.64)	< 0.01	2.46(2.20,2.75)	< 0.01
overweight	365.81	< 0.01	1.51(1.33,1.73)	< 0.01	1.79(1.58,2.03)	< 0.01
hypercholesterolemia	25.63	< 0.01	1.00(0.86,1.17)	1.00	0.99(0.84,1.16)	0.88
hypertriglyceridemia	190.26	< 0.01	1.16(1.05,1.31)	0.01	1.27(1.13,1.42)	< 0.01
low HDL	1.13	0.29	/	/	/	/
high LDL	7.42	0.01	1.01(0.87,1.17)	0.90	1.01(0.87,1.16)	0.94
systolic hypertension	266.15	< 0.01	1.31(1.14,1.51)	< 0.01	1.34(1.17,1.55)	< 0.01
diastolic hypertension	229.78	< 0.01	1.12(0.98,1.28)	0.09	1.15(1.00,1.31)	0.05

^a χ² value of log-rank test; ^bP value of log-rank test; ^c HRs in Cox regression model with adjusted factors: FLD, male sex, middle-aged and elderly, overweight, hypercholesterolemia, hypertriglyceridemia, low HDL, systolic hypertension, diastolic hypertension; ^dP value of HR^c; ^e HR in Cox regression model with adjusted factors: male sex, age group, BMI group, TC group, TG group, LDL group, SBP group, DBP group; ^fP value of HR ^e

ISSN: 1472-6823